The Jiangsu Oncology New Technology Medical Center was inaugurated in Nanjing Jiangbei New Area Sunday morning, becoming the province's first new technology medical center.
In order to tackle the prominent bottlenecks in the development of malignant tumor diagnosis and treatment technology, with the approval of the Jiangsu Provincial Health Commission, the Jiangsu Provincial Cancer New Technology Medical Center was inaugurated Sunday in Jiangbei International Hospital, Drum Tower Hospital, Nanjing University School of Medicine.
Mu Genglin, Secretary of the Party Committee and Dean of the Drum Tower Hospital, Nanjing University School of Medicine
Nanjing Gulou Hospital has competitive strength
in oncology with its strength
in digestive tract tumors
ranking third in the country
and the original introduction
and development of new tumor technologies
ranking first in Jiangsu
At present, the Oncology Department of Gulou Hospital Affiliated to Nanjing University School of Medicine has made major breakthroughs in tumor precision medicine and tumor immunotherapy.
In China, gastric cancer is the second largest type of cancer after lung cancer. Since early symptoms are not obvious, about 80% of gastric cancer patients are already in the middle and advanced stages when they are diagnosed, making treatment very difficult.
The Liu Baorui team from the Oncology Department of Nanjing Gulou Hospital modified the surface of T cells in immune cells, which has increased the accumulation and penetration of modified T cells in tumor tissue by 10 times, breaking the bottleneck of advanced gastric cancer treatment.
Liu Baorui, Deputy Dean of Drum Tower Hospital, Nanjing University School of Medicine
We are the national advocates
of individualized drug treatments for tumors
including tumor nano-based vaccines
and a series of technologies
We have made some bold explorations
in these areas
and some of them have obtained better clinical signs
